LONDON, April 7 (Reuters) - Britain should not give Oxford
University/AstraZeneca's vaccine to under 30s where
possible, Britain's Joint Committee on Vaccination and
Immunisation (JCVI) said on Wednesday, due to a very rare side
effect of blood clots in the brain.
"Based on the available data and evidence, JCVI has advised
that it is preferable for adults aged under 30 with no
underlying conditions to be offered an alternative to the
AstraZeneca vaccine where available," said Wei Shen Lim,
COVID-19 Chair for JCVI.
(Reporting by Alistair Smout, Guy Faulconbridge and Kate
Holton; editing by James Davey)